XDNA.TO iShares Genomics Immunology and Healthcare Index ETF CAD
The fund holds a concentrated portfolio of global companies in the biopharmaceutical and healthcare equipment and services industries that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering. In addition to these industry screens, companies must also meet certain size and liquidity measures for index eligibility. The underlying index then assigns a Relationship Keyword Score to each of the eligible companies using the FactSet Supply Chain Relationships database in search for keywords related to Genomics and Immuno Biopharmaceutical products and technologies. The top 50 names with the highest scores are included in the index. Holdings are weighted by market-cap and are constrained such that no individual security exceeds 4% weight of the portfolio. The index rebalances semi-annually.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| XDNA.TO | -11.5% | -4.2% | +47.2% | +45.9% | +24.0% | — |
| Equity average (1460 funds) | -5.4% | -4.7% | +1.4% | +3.9% | +11.9% | +4.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$15K net.
Holdings · as of Nov 20, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | MRNA MODERNA | 13.00% |
| 2 | GMAB.CO GENMAB | 6.45% |
| 3 | TWST TWIST BIOSCIENCE | 4.99% |
| 4 | REGN REGENERON PHARMACEUTICALS | 4.50% |
| 5 | BAYN.DE BAYER AG | 4.44% |
| 6 | 4502.T TAKEDA PHARMACEUTICAL | 4.40% |
| 7 | EXEL EXELIXIS INC | 3.86% |
| 8 | VRTX VERTEX PHARMACEUTICALS | 3.61% |
| 9 | ROP.SW ROCHE PS PAR AG | 3.55% |
| 10 | INCY INCYTE CORP | 3.50% |
| 11 | MRK MERCK & CO INC | 3.40% |
| 12 | RVMD REVOLUTION MEDICINES | 3.30% |
| 13 | SAN.PA SANOFI SA | 3.16% |
| 14 | IPN.PA IPSEN SA | 3.03% |
| 15 | XDNA.TO BIONTECH SE ADR | 2.86% |
| 16 | GSK.L GLAXOSMITHKLINE | 2.86% |
| 17 | IOVA IOVANCE BIOTHERAPEUTICS INC | 2.75% |
| 18 | IBRX IMMUNITYBIO | 2.40% |
| 19 | CAI CARIS LIFE SCIENCES | 2.21% |
| 20 | IDYA IDEAYA BIOSCIENCES | 2.11% |
| 21 | 4528.T ONO PHARMACEUTICAL | 1.72% |
| 22 | RCUS ARCUS BIOSCIENCES | 1.28% |
| 23 | NVAX NOVAVAX | 1.17% |
| 24 | VIR VIR BIOTECHNOLOGY | 1.15% |
| 25 | CRSP CRISPR THERAPEUTICS AG | 1.08% |
| 26 | NUVB NUVATION BIO CLASS A | 0.91% |
| 27 | PSNL PERSONALIS | 0.89% |
| 28 | XNCR XENCOR | 0.74% |
| 29 | 6887.HK SUNSHINE LAKE PHARMA LTD CLASS H | 0.74% |
| 30 | RIGL RIGEL PHARMACEUTICALS | 0.71% |
| 31 | KURA KURA ONCOLOGY | 0.61% |
| 32 | CRVS CORVUS PHARMACEUTICALS | 0.61% |
| 33 | JANX JANUX THERAPEUTICS | 0.57% |
| 34 | VSTM VERASTEM INC | 0.54% |
| 35 | PACB PACIFIC BIOSCIENCES OF CALIFORNIA | 0.49% |
| 36 | 2595.HK GENFLEET THERAPEUTICS (SHANGHAI) I | 0.44% |
| 37 | VLA.PA VALNEVA | 0.42% |
| 38 | NTLA INTELLIA THERAPEUTICS | 0.39% |
| 39 | DNA GINKGO BIOWORKS HOLDINGS CLASS A | 0.37% |
| 40 | 2696.HK SHANGHAI HENLIUS BIOTECH H | 0.35% |
| 41 | CTMX CYTOMX THERAPEUTICS | 0.34% |
| 42 | DSGN DESIGN THERAPEUTICS | 0.34% |
| 43 | OCGN OCUGEN | 0.24% |
| 44 | PRME PRIME MEDICINE | 0.11% |
Sector breakdown
Country breakdown
Distributions
No distributions on file.
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in XDNA.TO in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 22, 2026. This is historical data, not investment advice. Report a data error
